CHRS
Coherus BioSciences Inc
1.10$
-3.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +78.8% | +294.6% | +13.4% | -16.0% | -8.9% | -38.8% | +311.1% | +105.8% | -19.3% | -29.2% | +30.9% | -28.8% | -42.4% | |
| – | – | +84.2% | +229.3% | +5.2% | -21.0% | +1.6% | -43.0% | +417.9% | +104.8% | -21.5% | -36.7% | +24.8% | -28.2% | -39.5% | |
| – | – | +171.9% | +280.2% | +5.2% | -21.0% | +1.6% | -43.0% | +145.5% | +204.6% | -22.9% | -84.8% | +61.9% | +22.4% | -29.5% | |
| – | – | +171.9% | +280.2% | +5.2% | -21.0% | +1.6% | -43.0% | +145.5% | +204.6% | -22.9% | -54.1% | -38.6% | +7.0% | +36.6% | |
| – | – | +143.7% | +999.2% | -63.1% | +19.2% | – | – | – | +10.6% | -21.7% | -10.6% | +136.9% | -53.0% | -84.9% | |
| – | – | -100.0% | -819,900,100.0% | – | – | – | – | +3,219.5% | -19.7% | -14.9% | +3.1% | +61.4% | +12.0% | -95.5% | |
| – | – | +8.6% | +156.6% | +134.9% | +2.6% | +18.6% | -47.9% | +147.6% | +190.8% | +32.3% | +34.0% | – | – | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +90.4% | +1,318.0% | -24.2% | -13.8% | |
| – | – | +418.0% | +34.1% | +82.1% | -27.4% | -17.0% | +4.5% | +120.0% | +84.6% | +3.7% | +6.3% | +33.1% | -29.5% | -66.0% | |
| – | – | +377.2% | -3.6% | +104.7% | -46.8% | -49.6% | +17.1% | +245.7% | +26.7% | +13.5% | -16.1% | +139.2% | -14.7% | -49.9% | |
| – | – | +141.8% | +167.2% | +114.9% | -96.4% | -73.4% | – | – | +42.6% | +11.5% | +23.7% | -50.3% | -21.2% | +8.1% | |
| – | – | -5.6% | +193.0% | +173.2% | -30.2% | -23.7% | -2.7% | +69.9% | -41.5% | +6.3% | -28.7% | +205.6% | -19.2% | -65.2% | |
| – | – | – | – | – | – | +1.3% | +1.5% | +73.0% | +111.6% | +8.2% | -44.7% | +109.8% | -44.0% | -86.0% | |
| – | – | -561.1% | – | -110.4% | – | +57.8% | -226.4% | – | +167.1% | -65.2% | -240.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +41.3% | +540.1% | -54.7% | +353.5% | +12.9% | +26.8% | +22.4% | +12.5% | +14.1% | -9.6% | +2.9% | +21.3% | +21.9% | +4.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.